Stock Valuation Using Algorithms: Up To 91.89% In 3 Months

Stock Valuation

This Stock Valuation forecast is designed for investors and analysts who need predictions of the best performing stocks for the whole Biotechnology Industry (See Industry Package). It includes 20 stocks with bullish and bearish signals and indicates the best biotech stocks to buy:

  • Top 10 biotech stocks for the long position
  • Top 10 biotech stocks for the short position

BioTech StocksPackage Name: BioTech Stocks
Forecast Length: 3 Months   (02/25/16– 05/25/16)
I Know First Average: 37.47%

stock valuation

The algorithm correctly predicted all 10 stocks forecasted to increase during the predicted time horizon of 3 Months in the bioTech-stocks package forecast from 02/25/2016. The most impressive prediction was for MDVN, which offered a return of 91.89% during the predicted time horizon to investors who bought this stock. Other impressive returns were KERX  and ARIA which increased by 62.86% and 59.49%, respectively. The average return from this forecast for investors was 37.47%, offering a premium to investors over the S&P 500 return of 8.33% during the predicted time horizon.

Windtree Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing novel surfactant therapies for respiratory diseases and other potential applications;

Algorithmic traders utilize these daily forecasts by the I Know First market prediction system as a tool to enhance portfolio performance, verify their own analysis and act on market opportunities faster. This forecast was sent to current I Know First algorithmic traders.

How to interpret this diagram

Please, note-for trading decisions use the most recent forecast. Get today’s forecast and Top stock picks.